Invision Diagnostics: Leading provider of mobile breast cancer screenings for women throughout the greater Charlotte area, as well as North & South Carolina. Contact us today to request a mammography bus for your community or corporate event!
Design, Setting, and Participants This open-label, phase 3 randomized clinical trial (MYSTIC) was conducted at 203 cancer treatment centers in 17 countries. Patients with treatment-naive, metastatic non–small cell lung cancer who had no sensitizing EGFR or ALK genetic alterations were randomized to...
In addition, MRD-negativity rates were also presented for patients achieving ≥CR in each cytogenetic subgroup. This study descriptively presents the results for the D-KRd and D-RVd groups side by side, and thus no statistical or treatment comparisons between the 2 groups were performed. Kaplan...
Nai Chien Yeat, Charlotte Lin, Monica Sager, Jimmy Lin. (2015) Cancer proteomics: developments in technology, clinical use and commercialization. Expert Review of Proteomics , 1-15 /Yeat NC, Lin C, Sager M, et al. Cancer proteomics: developments in technology, clinical use and ...
After researching other sites to make a comparison of treatment centers, Loma Linda stands out from the rest. “Making Man Whole” is the healing process which makes the difference. With 23 years of experienced radiation department staff, makes the decision, where to be treated easy. Clyde Mars...
"With each of our 16 breast imaging centers now equipped with the latest Volpara software tool suite, Charlotte Radiology can better fulfill our most important mission – diagnosing breast cancer early and supporting our patients through their treatment," said Lindsay Muns, ...
Anti-Mullerian hormone has been proposed as a potential treatment for endometrial cancers (Kim et al, 2014). However, although experimental models demonstrate an inhibiting effect of AMH on endometrial cancer growth, our findings in premeno- pausal women do not support a role for circulating AMH ...
Jean Pierre Bizzari, MD, Chair of Nordic Nanovector’s Clinical Committee, said: "We are extremely encouraged by the preliminary data we are seeing both in terms of efficacy and safety profile. This novel ‘one-time` treatment in this underserved resistant/refractory patient population is especial...
Analyses were conducted in SAS version 9.4 (The SAS Institute, Cary, NC) and R Core Team (2018). Results Patient characteristics One thousand nine hundred and ninety-six SMM patients from 75 centers in 23 countries were included. Baseline characteristics are in Table 1. The median age at ...
If proven to be effective and efficient, this program could be used in a health-care context as a complementary form of psychological treatment for breast cancer patients. Objectives In the study we present the detailed research protocol of a randomized controlled trial (RCT) to assess the ...